Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2006 3
2007 5
2008 6
2009 6
2010 4
2011 9
2012 15
2013 29
2014 18
2015 13
2016 11
2017 16
2018 12
2019 6
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22761478

136 results
Results by year
Filters applied: . Clear all
Page 1
Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis.
Colmers IN, Bowker SL, Majumdar SR, Johnson JA. Colmers IN, et al. CMAJ. 2012 Sep 4;184(12):E675-83. doi: 10.1503/cmaj.112102. Epub 2012 Jul 3. CMAJ. 2012. PMID: 22761478 Free PMC article.
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.
Turner RM, Kwok CS, Chen-Turner C, Maduakor CA, Singh S, Loke YK. Turner RM, et al. Br J Clin Pharmacol. 2014 Aug;78(2):258-73. doi: 10.1111/bcp.12306. Br J Clin Pharmacol. 2014. PMID: 24325197 Free PMC article.
Pioglitazone use and risk of bladder cancer: population based cohort study.
Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L. Tuccori M, et al. BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541. BMJ. 2016. PMID: 27029385 Free PMC article.
Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis.
Levin D, Bell S, Sund R, Hartikainen SA, Tuomilehto J, Pukkala E, Keskimäki I, Badrick E, Renehan AG, Buchan IE, Bowker SL, Minhas-Sandhu JK, Zafari Z, Marra C, Johnson JA, Stricker BH, Uitterlinden AG, Hofman A, Ruiter R, de Keyser CE, MacDonald TM, Wild SH, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group; Diabetes and Cancer Research Consortium. Levin D, et al. Diabetologia. 2015 Mar;58(3):493-504. doi: 10.1007/s00125-014-3456-9. Epub 2014 Dec 7. Diabetologia. 2015. PMID: 25481707
Increased risk of bladder cancer with pioglitazone therapy in patients with diabetes: a meta-analysis.
Zhu Z, Shen Z, Lu Y, Zhong S, Xu C. Zhu Z, et al. Diabetes Res Clin Pract. 2012 Oct;98(1):159-63. doi: 10.1016/j.diabres.2012.05.006. Epub 2012 Jun 16. Diabetes Res Clin Pract. 2012. PMID: 22705039
Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis.
Colmers IN, Bowker SL, Johnson JA. Colmers IN, et al. Diabetes Metab. 2012 Dec;38(6):475-84. doi: 10.1016/j.diabet.2012.06.003. Epub 2012 Oct 5. Diabetes Metab. 2012. PMID: 23041441 Review.
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.
Han E, Jang SY, Kim G, Lee YH, Choe EY, Nam CM, Kang ES. Han E, et al. Medicine (Baltimore). 2016 Feb;95(6):e2786. doi: 10.1097/MD.0000000000002786. Medicine (Baltimore). 2016. PMID: 26871835 Free PMC article.
Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis.
He S, Tang YH, Zhao G, Yang X, Wang D, Zhang Y. He S, et al. Tumour Biol. 2014 Mar;35(3):2095-102. doi: 10.1007/s13277-013-1278-x. Epub 2013 Oct 4. Tumour Biol. 2014. PMID: 24092576
Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.
Ferwana M, Firwana B, Hasan R, Al-Mallah MH, Kim S, Montori VM, Murad MH. Ferwana M, et al. Diabet Med. 2013 Sep;30(9):1026-32. doi: 10.1111/dme.12144. Diabet Med. 2013. PMID: 23350856 Review.
Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.
Korhonen P, Heintjes EM, Williams R, Hoti F, Christopher S, Majak M, Kool-Houweling L, Strongman H, Linder M, Dolin P, Bahmanyar S. Korhonen P, et al. BMJ. 2016 Aug 16;354:i3903. doi: 10.1136/bmj.i3903. BMJ. 2016. PMID: 27530399 Free PMC article.
136 results
Jump to page
Feedback